Aenova Boosts Tablet Production with New Facility
The move should increase Aenova's production of tablets by an estimated 10 billion tablets each year, according to Aenova.
Contract manufacturer Aenova Group (Pähl, Germany) just opened a state-of-the-art production facility in Tittmoning, Germany. The move should increase Aenova's production of tablets by an estimated 10 billion tablets each year, according to Aenova.
Aenova Group is a contract manufacturer of granules, tablets, film-coated tablets, and dragées. The company’s new facility reduces processing times for the manufacturing of high-volume pharmaceuticals and dietary supplements.
An opening ceremony for the Tittmoning facility was scheduled for September 29.
Aenova also offers individual packaging solutions. For more information, visit Aenova's website.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
